Preconditioning with SDF-1 Improves Therapeutic Outcomes of Bone marrow-derived Mesenchymal Stromal Cells in a Mouse Model of STZ-induced Diabetes

BACKGROUND: Nowadays, transplantation of Bone marrow-derived Mesenchymal Stromal Cells (BMSCs) is currently an important alternative therapy for patient’s type 1 diabetes mellitus. But a number of critical obstacles lie ahead of this new strategy including reducing stem cell homing to the damaged ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gholami Farashah, Mohammad Sadegh, Pasbakhsh, Parichehr, Omidi, Ameneh, Nekoonam, Saied, Aryanpour, Roya, Regardi Kashani, Iraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Research Institute 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359696/
https://www.ncbi.nlm.nih.gov/pubmed/30800241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359696/
https://www.ncbi.nlm.nih.gov/pubmed/30800241

Ejemplares similares